Janus Henderson Group’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,742,123
| Closed | -$4.32M | – | 2613 |
|
|
2022
Q1 | $4.32M | Sell |
1,742,123
-1,780,889
| -51% | -$4.42M | ﹤0.01% | 1042 |
|
|
2021
Q4 | $21.2M | Sell |
3,523,012
-10,369
| -0.3% | -$62.3K | 0.01% | 772 |
|
|
2021
Q3 | $23.5M | Buy |
3,533,381
+382,214
| +12% | +$2.55M | 0.01% | 754 |
|
|
2021
Q2 | $21M | Buy |
3,151,167
+213,985
| +7% | +$1.42M | 0.01% | 777 |
|
|
2021
Q1 | $27.2M | Buy |
2,937,182
+799,511
| +37% | +$7.4M | 0.01% | 703 |
|
|
2020
Q4 | $38.4M | Buy |
2,137,671
+1,124,853
| +111% | +$20.2M | 0.02% | 603 |
|
|
2020
Q3 | $14.4M | Buy |
+1,012,818
| New | +$14.4M | 0.01% | 770 |
|